IDXX Lost 6.0% In A Day. Do You Buy Or Wait?
IDEXX Laboratories (IDXX) stock is down 6.0% in a day. Already own the stock? You might want to consider holding it. Planning to buy? This might be your opportunity. Consider the following data:
- A $52 Bil company with $4.0 Bil in revenue currently trading at $641.94.
- Last 12 month revenue growth of 6.7% and operating margin of 31.1%.
- Has Debt to Equity ratio of 0.0 and Cash to Assets ratio of 0.0
- Currently trading at P/E multiple of 52.4 and P/EBIT multiple of 40.9
- Has returned (median) 99.4% within a year following sharp dips since 2010. See IDXX Dip Buy Analysis.
While we like to buy dips if the fundamentals check out – for IDXX, see Buy or Sell IDXX Stock – we are wary of falling knives. Specifically, it is worth trying to answer if things get really bad, and IDXX drops another 20-30% to $449.36 levels, will we be able to hold on to the stock? What is the worst case scenario? We call it downturn resilience.
Below is a deep dive into IDEXX Laboratories (IDXX) downturn resilience – specifically, its performance vs the market during past crises? Turns out, the stock saw an impact slightly worse than the S&P 500 index during various economic downturns.
IDXX develops and distributes veterinary diagnostic products, instruments, consumables, and test kits for companion animals, livestock, poultry, dairy, and water quality testing markets.
- Nutanix Stock To $33?
- Texas Pacific Land Stock Drop Looks Sharp, But How Deep Can It Go?
- Advanced Micro Devices Stock Drop Looks Sharp, But How Deep Can It Go?
- Would You Still Hold Broadcom Stock If It Fell Another 30%?
- Would You Still Hold Modine Manufacturing Stock If It Fell Another 30%?
- Why Is Lyft Stock Down 16%?
2022 Inflation Shock
- IDXX stock fell 54.0% from a high of $705.76 on 5 August 2021 to $324.64 on 14 October 2022 vs. a peak-to-trough decline of 25.4% for the S&P 500.
- The stock is yet to recover to its pre-Crisis high
- The highest the stock has reached since then is $682.78 on 4 August 2025 , and currently trades at $641.94
| IDXX | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -54.0% | -25.4% |
| # of Days for Full Recovery | Not Fully Recovered | 464 |
2020 Covid Pandemic
- IDXX stock fell 37.1% from a high of $290.97 on 19 February 2020 to $182.94 on 23 March 2020 vs. a peak-to-trough decline of 33.9% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 7 May 2020
| IDXX | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -37.1% | -33.9% |
| # of Days for Full Recovery | 45 | 148 |
2018 Correction
- IDXX stock fell 30.8% from a high of $254.46 on 29 August 2018 to $176.18 on 24 December 2018 vs. a peak-to-trough decline of 19.8% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 24 May 2019
| IDXX | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -30.8% | -19.8% |
| # of Days for Full Recovery | 151 | 120 |
2008 Global Financial Crisis
- IDXX stock fell 57.3% from a high of $32.11 on 15 November 2007 to $13.72 on 20 November 2008 vs. a peak-to-trough decline of 56.8% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 23 April 2010
| IDXX | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -57.3% | -56.8% |
| # of Days for Full Recovery | 519 | 1480 |
Worried that IDXX could fall much more? You could take a look at the Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.